HPE vs VYNE · P/E 20, rev $32.19B vs rev $501.0K
Hewlett Packard Enterprise Co (HPE) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
HPE currently screens at market cap $27.19B and trailing P/E 19.9. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the HPE and VYNE stock pages for the full models.
Not investment advice.